ARS Pharmaceuticals, Inc.
SPRY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $8 | -$54 | -$35 | -$20 |
| Dep. & Amort. | -$7 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $15 | $9 | $6 | $3 |
| Change in WC | -$2 | -$7 | -$13 | -$0 |
| Other Non-Cash | $0 | -$7 | $1 | -$0 |
| Operating Cash Flow | $14 | -$59 | -$40 | -$18 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$356 | -$272 | $0 | $0 |
| Inv. Sales/Matur. | $258 | $185 | $0 | $0 |
| Other Inv. Act. | -$8 | $0 | $0 | $0 |
| Investing Cash Flow | -$106 | -$87 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $69 | $0 | -$9 | -$2 |
| Stock Issued | $3 | $7 | $1 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $199 | $55 |
| Financing Cash Flow | $72 | $7 | $191 | $53 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$20 | -$140 | $150 | $36 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $71 | $211 | $60 | $25 |
| End Cash | $51 | $71 | $211 | $60 |
| Free Cash Flow | $13 | -$59 | -$40 | -$18 |